Japanese Encephalitis (JE)

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
 
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.
 
Undefined

The world needs made-in-China vaccines, despite a recent spate of deaths

China’s ambition to become a major player in vaccines has hit a snag: the deaths of 17 newborn infants who had just received Chinese-made hepatitis B vaccines.

Undefined

China enters global vaccine marketplace

A Chinese-made vaccine has been given a stamp of approval by the World Health Organization (WHO) for the first time. The move could herald a step towards China becoming a global vaccine maker.

The vaccine protects children against Japanese encephalitis (JE), a viral brain infection spread by mosquitoes that is common in parts of east and south Asia. The vaccine, formally known as SA 14-14-2, was added to the WHO's prequalified medicines list last week, giving it a WHO quality and safety endorsement. The practical implication is that it can be used by United Nations agencies.

Undefined

Japanese encephalitis vaccine achieves WHO prequalification, a key step in expanding access and protecting more children

An affordable vaccine to protect children against deadly Japanese encephalitis (JE) has been prequalified by the World Health Organization (WHO), paving the way to reach millions more children across Asia at risk for the disease. The announcement was made today by PATH, a global health nonprofit organization, and China National Biotec Group Co., Ltd.

Undefined

Bharat Biotech launches JENVAC™ - a Novel fully Indigenous Inactivated Japanese Encephalitis vaccine

HYDERABAD/NEW DELHI, India, October 4th 2013: Genome Valley based Vaccine and Bio-Therapeutic Innovator; Bharat Biotech today announced the launch of its Vero cell-derived purified inactivated JE vaccine “JENVAC™” which received the manufacturing and marketing approvals by Drug Controller General of India (DCGI). It is a fully indigenous vaccine commercialized using strain, identified, characterized, manufactured and tested in India.

Undefined

First indigenous Japanese Encephalitis vaccine awaits formal launch

First indigenous Japanese Encephalitis vaccine awaits formal launch

 

September 5, 2013 -- The first totally indigenous vaccine against Japanese Encephalitis (JE)--created using an Indian strain of the virus--has received the nod of Drug Controller General of India (DCGI). The vaccine is going to be formally launched for public use soon.

Undefined

JE, West Nile turning killers?

JE, West Nile turning killers?

 

August 26, 2013 -- A serious threat of Japanese Encephalitis (JE) or West Nile (WN) outbreak looms large over Alappuzha district, which is prone to water stagnation and consequent mosquito menace post-monsoon.

Undefined

Vigilance hits virus war: Study shows poor surveillance on encephalitis

Vigilance hits virus war: Study shows poor surveillance on encephalitis

 

August 18, 2013 -- Poor surveillance, incomplete diagnosis and unsubstantiated scientific claims have stymied India’s efforts to control the mystery encephalitis that has killed 3,000 children in eastern India over the past three years, health researchers have said.

Undefined

Pages